Loading resource…

Cem Akin, Michel Arock, Melody C. Carter, Tracy I. George, Peter Valent
This primer provides a comprehensive overview of mastocytosis, detailing its classification into cutaneous mastocytosis, systemic mastocytosis (SM), and mast cell sarcoma. It highlights the advancements in diagnosis, prognosis, and management over the past 15 years, including the development of targeted therapies for advanced SM. The document emphasizes the importance of symptomatic therapy and the recognition of comorbidities associated with mastocytosis.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Myeloproliferative Neoplasms
Same clinical topic · Hematology

MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology

PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology

COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology

VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology

IRON DEFICIENCY
Same clinical topic · Hematology

MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology

ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology

POST-TRANSPLANTATION CYCLOPHOSPHAMIDE AND ANTHYMOCTE GLOBULIN IN 8/10 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATION
Same clinical topic · Hematology